Navigating AI-Life Sciences Partnerships: Mitigating IP Risks for Sustainable Growth
Artificial intelligence (AI) is closely watched by stakeholders in healthcare and life sciences. The ongoing development of AI-enabled solutions is bringing radical transformations in these sectors – impacting drug discovery, disease diagnosis, clinical trials, and precision medicine. Consequently, life science firms are increasingly investing in AI tools, as reported by Law360. When life sciences and…